We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RICE
201
DELISTED
Rice Energy Inc.
RICE
$16.5M 0.14%
+620,651
New +$13.8M
EXAS
202
DELISTED
Exact Sciences
EXAS
$15.9M 0.13%
450,447
-327,301
-42% -$10.1M
OXFD
203
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$15.8M 0.13%
941,625
-10,844
-1% -$162K
TWLO icon
204
Twilio
TWLO
$29.8B
$15.8M 0.13%
542,706
+342,706
+171% +$9.37M
KMB icon
205
Kimberly-Clark
KMB
$35.7B
$15.7M 0.13%
+121,857
New +$15.9M
CVSA
206
Covista Inc
CVSA
$4.34B
$15.7M 0.13%
412,442
+12,442
+3% +$464K
TIF
207
DELISTED
Tiffany & Co.
TIF
$15.6M 0.13%
+166,551
New +$15.3M
EACQ
208
DELISTED
Easterly Acquisition Corp
EACQ
$15.3M 0.13%
1,523,414
UAL icon
209
United Airlines
UAL
$41.7B
$14.8M 0.12%
197,300
-1,033,583
-84% -$78M
AAP icon
210
Advance Auto Parts
AAP
$3.36B
$14.4M 0.12%
123,091
+88,091
+252% +$12.1M
BG icon
211
Bunge Global
BG
$20.2B
$14.3M 0.12%
+192,318
New +$14.6M
CPAA
212
DELISTED
Conyers Park Acquisition Corp. Class A Common Stock
CPAA
$14M 0.12%
+1,191,582
New +$14M
GOV
213
DELISTED
Government Properties Income Trust
GOV
$14M 0.12%
+762,650
New +$16.6M
NKE icon
214
Nike
NKE
$63.3B
$13.9M 0.12%
+236,028
New +$12.7M
SWN
215
DELISTED
Southwestern Energy Company
SWN
$13.7M 0.11%
+2,252,368
New +$15.6M
NPTN
216
DELISTED
NEOPHOTONICS CORP
NPTN
$13.6M 0.11%
+1,762,265
New +$14.9M
BKD icon
217
Brookdale Senior Living
BKD
$3.43B
$13.1M 0.11%
888,427
-1,326,318
-60% -$18.3M
VEAC
218
CALL
DELISTED
Vantage Energy Acquisition Corp. Class A
VEAC
$13M 0.11%
+1,333,333
New +$13M
MLNX
219
DELISTED
Mellanox Technologies, Ltd.
MLNX
$12.8M 0.11%
295,603
+180,096
+156% +$8.54M
QTS
220
DELISTED
QTS REALTY TRUST, INC.
QTS
$12.8M 0.11%
243,903
-303,090
-55% -$15.7M
ACAD icon
221
Acadia Pharmaceuticals
ACAD
$4.39B
$12.5M 0.1%
446,430
+73,593
+20% +$2.19M
MYCC
222
DELISTED
ClubCorp Holdings, Inc.
MYCC
$12.1M 0.1%
920,244
+230,162
+33% +$3.13M
FBM
223
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$11.9M 0.1%
922,313
+575,513
+166% +$8.61M
PRAA icon
224
PRA Group
PRAA
$666M
$11.6M 0.1%
+306,618
New +$10.7M
BAS
225
DELISTED
Basis Energy Services, Inc.
BAS
$11.6M 0.1%
+465,333
New +$12.9M

Similar funds

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.